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Phosphoenolpyruvate carboxylase (PEPC) is a key enzyme of C4 photosynthesis. Besides, non-photo-
synthetic isoforms of PEPC are found in bacteria and all types of plants, although not in animals or
fungi. A single residue in the allosteric feedback inhibitor site of PEPC was shown to adjust the afﬁn-
ity of the photosynthetic and non-photosynthetic isoforms for feedback inhibition by metabolites of
the C4 pathway. Here, we applied computational screening and biochemical analyses to identify
molecules that selectively inhibit C4 PEPC, but have no effect on the activity of non-photosynthetic
PEPCs. We found two types of selective inhibitors, catechins and quinoxalines. Binding constants in
the lower lM range and a strong preference for C4 PEPC qualify the quinoxaline compounds as
potential selective herbicides to combat C4 weeds.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction C4 plants would be of outmost importance for the agribusiness andC4 plants are characterized by high rates of photosynthesis and
efﬁcient use of water and nitrogen in hot and dry environments.
The high efﬁciency of C4 plants is attributed to a speciﬁc metabolic
pathway, the C4 acid cycle. This pathway separates primary carbon
ﬁxation in the mesophyll cells from carbon release to the Calvin
Cycle in the bundle sheat cells, allowing the plant to ﬁx inorganic
carbon more efﬁciently than C3 plants where primary carboxyla-
tion takes place directly in the Calvin Cycle [1].
While themajority of the world’s plants including important crop
plants such as rice, wheat, barley and oat operate the typical C3 pho-
tosynthetic pathway, most of the world’s worst weeds are C4 plants
taking advantage of the increased photosynthetic efﬁciency at high
light and warm climatic conditions [2]. Speciﬁc herbicides againsta major turning point in the control of the worst weeds in the world.
The C4 metabolism offers three potential targets for a selective
herbicide. The ﬁrst target is the enzyme PEPC catalyzing primary
carbon ﬁxation by converting phosphoenolpyruvate (PEP) and
bicarbonate into the 4-carbon compound oxaloacetate [3]. Second
targets are the malic enzyme (ME) [4] or the enzyme PEP carboxy-
kinase (PEPCK), the decarboxylases that catalyze the release of car-
bon dioxide to the Calvin Cycle in the bundle sheath cells [1]. The
third target is the enzyme pyruvate phosphate dikinase (PPDK),
which regenerates PEP as the primary carbon dioxide acceptor
[2]. Depending on the subcellular localization and according to
the decarboxylating enzyme located in the bundle sheath cells
three variations to the C4 acid cycle have been deﬁned, and the
C4 plants have been classiﬁed into three groups [5–7].
PEPC is a target common to all variants of C4 metabolism. How-
ever, due to the high sequence homology between the C4 PEPC and
the non-photosynthetic C3 PEPCs, which have essential anaplerotic
functions in the general C3 metabolism in plants and other organ-
ism [8–10], it is not obvious to use this enzyme as selective target.
Nevertheless, a number of PEP analogues such as 3,3-dichloro-2-
(dihydroxyphosphinoyl-methyl)-propenoate (DCDP) have been
explored as C4 plant-selective inhibitors [11–14]. However, these
compounds also inhibit C3 PEPCs at rates between 12–46% [12]
and do not inhibit growth of C4 plants [2].
As the photosynthetic and non-photosynthetic isoforms of PEPC
substantially differ in their sensitivity towards feedback inhibition
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envisioned that the molecular basis of the different feedback
regulation could be exploited for the development of C4 speciﬁc
inhibitors.
Crystal structures of a non-photosynthetic PEPC from
Escherichia coli and of a photosynthetic PEPC from the C4 plant
maize have been solved [17] and residues involved in the binding
of the feedback inhibitor malate were identiﬁed. However, in these
studies no speciﬁc residue or motif was found to account for the
increased malate tolerance of the photosynthetic C4 PEPC in com-
parison to the C3 PEPC. In contrast, recent biochemical and struc-
tural studies from our lab on the PEPC from Flaveria pringlei (C3
PEPC) and from Flaveria trinervia (C4 PEPC) – which share 94%
sequence identity – revealed that a single residue in the feedback
inhibitor site accounts for the drastic differences in malate toler-
ance of both enzymes. In the C3 PEPC an arginine (aa 884 Flaveria
numbering) supports tight inhibitor binding, while at the same
position in C4 PEPC a glycine confers reduced inhibitor afﬁnity
[18]. Alignments with other protein sequences from C3 and C4 PEP-
Cs show that the arginine is conserved in all C3 PEPCs as in typical
crop plants. C4 PEPCs from weed plants such as Imperata cylindrica
(Cogon Grass), Panicum capillare (Witch Grass), Bothriochloa sac-
charoides (Silver bluestem), Sorghum halepense (Johnson Grass),
Panicummiliaceum (Proso Millet), Cenchrus echinatus (Buffel Grass),
Setaria plicata (ko-sasakibi), Setaria palmifolia (Palm Grass), Zuloa-
gaea bulbosa (Texas Grass) or Paspalum conjugatum (Buffalo Gras)
have a glycine, serine or glutamine residue at this position provid-
ing reduced steric constraints to the feedback inhibitor site [19].
Consequently, we took advantage of this primary structural
difference in the feedback inhibitor site of C3 and C4 PEPC to obtain
selective inhibitors of the photosynthetic C4 PEPC isoform, thereby
providing potential novel efﬁcient and selective herbicides that
could prevent the deleterious effect of C4 weeds on C3 crops.
2. Material and methods
2.1. Virtual screening of selective inhibitors of C4 PEPC
To ﬁnd potent selective inhibitors of C4 PEPC, a docking study
was performed using PyRX 0.8 [20] based on the X-ray structure
of C4 PEPC from F. trinervia (3zge) and C3 PEPC from F. pringlei
(3zgb) [18]. The natural inhibitor aspartate bound to the allosteric
feedback inhibitor site in both structures was removed from the
structures before docking. Structures of small molecules were
selected from standard compound libraries (ChemBank, NCI Data-
Base, KEGG Database) and a library assembled from the Plant
Metabolome Database. A box with default dimensions around the
location of the experimental pose of the aspartate inhibitor (i.e.,
ASP A1967) was deﬁned for docking of the small molecule com-
pounds. The Lamarckian Genetic Algorithm was used for ligand
conformational searching and default parameters were used for
docking. During docking, a maximum number of ﬁve poses per
ligand were obtained. The most reliable pose was selected by tak-
ing advantage of the information provided by the binding position
of the aspartate inhibitor in the crystal structures of the Flaveria
PEPCs. Potential selective inhibitor candidates of C4 PEPC were
selected by comparing binding afﬁnities of compounds for the C4
enzyme and the C3 isoform. In order to select for high afﬁnity
binding at the C4 PEPC feedback site a threshold afﬁnity of
P8.5 kcal mol1 was applied corresponding to predicted binding
afﬁnities of the putative inhibitors in the lM range.
2.2. Heterologous gene expression and protein puriﬁcation
Gene expression and puriﬁcation of the recombinant PEPC from
F. trinervia and F. pringlei were performed as described in Pauluset al. [18]. The modiﬁed pETEV16 vector (Novagene) used in our
study contains an N-terminal His-Tag with a TEV protease cleavage
site followed by the sequence encoding the plant PEPC gene (ppcA,
EMBL numbering F. trinervia X61304 and F. pringlei Z48966). The
E. coli strains BL21(DE) and BL21-Gold(DE) were used for heterolo-
gous expressions of the ppcA genes in 2YT-medium. Expression
was started at cell density of 0.8–1.0 with 0.5 mM isopropyl-b-D-
1-thiogalactopyranoside. Bacteria cells were harvested after over
night incubation at 16 C and 180 rpm.
For puriﬁcation, cells expressing the C3 PEPC from F. pringlei or
the C4 PEPC from F. trinervia were resuspended in 50 mM Tris/HCl
pH 7.5, 150 mM NaCl, 10 mM MgCl2, supplied with DNAse and
lysozyme and subsequently lysed using a cell disruptor (Constant
Systems). The cell lysate was clariﬁed by centrifugation at
30000–40000g.
The supernatant containing the PEPC proteins was puriﬁed by
afﬁnity chromatography on His-Trap FF or HP columns (GE
Healthcare) using the Äkta prime plus HPLC system. After a wash-
ing step with 150 mM imidazole, PEPCs were eluted with 500 mM
imidazole in the puriﬁcation buffer. Imidazole was removed by
ultraﬁltration (cutoff volume 50 kDa) followed by a desalting-step
on a PD-10 column (GE Healthcare). The protein was concentrated
to 7–16 mg/mL and stored in 30 or 50% (v/v) glycerol at 20 or
80 C, respectively.
2.3. Inhibition of C3 and C4 PEPC activity by molecules selected from
the VDS approach
The effect of potential selective inhibitors of C4 PEPC on the cat-
alytic activity of puriﬁed PEPCs from F. trinervia and F. pringlei was
measured by a coupled spectrophotometrical assay. In this assay
carboxylation of PEP by PEPC was linked to the oxidation of NADH
by NADH-malate dehydrogenase. The assay was performed in a
sample volume of 600 lL at a reaction temperature of 25 C. PEPC
activity (U min1) was determined in reaction buffer (50 mM
HEPES/KOH pH 8.0, 10 mM MgCl2, 10 mM KHCO3 containing
150 lM NADH, 5 mM PEP and 8.3 U mL1 malate dehydrogenase).
The reaction was started by the addition of puriﬁed PEPC. One
enzyme unit is deﬁned as the oxidation of one lmol NADH per
minute at 25 C. The enzyme samples were diluted to 2.5 U mL1
in dilution buffer (10 mM HEPES/KOH pH 8.0, 1 mM dithiothreitol,
5% (v/v) glycerol).
To determine the half maximal (50%) inhibitory concentration
IC50 of catechin and quinoxaline compounds identiﬁed as potential
selective inhibitors of the C4 PEPC, the activity of PEPCs from F.
pringlei and F. trinervia was measured over a range of concentra-
tions of the inhibitors. The IC50 of the different compounds for C4
PEPC or C3 PEPC was determined from these data with the GraFit
Software (Erithacus Software Limited, UK). Compounds were dis-
solved in dimethyl sulfoxide (DMSO) and controls with the solvent
were run for background correction. Puriﬁed PEPC was pre-incu-
bated with the compounds for 5 min before the catalytic reaction
was started by the addition of PEP at twofold Km concentration
(F. trinveria 1.4 mM and F. pringlei 0.14 mM PEP). Concentration
for catechin compounds ranged from 50–400 lM for (+)-catechin
and from 5–100 lM for ()-epigallocatechin gallate. The quinoxa-
lines compounds were tested from 10–100 lM for AG 1433 and
from 5–50 lM for 2-(4-methoxyphenyl)-3-phenyl-quinoxaline.
Activity at 0 mM compound was set to 100% enzyme activity. Data
were measured in triplicate for each concentration.
2.4. Binding studies of potential C4 selective inhibitors in the presence
and absence of the natural feedback inhibitor malate
Dissociation constants (Kd) of C4 PEPC from F. trinervia for the
potential C4 selective inhibitors identiﬁed in our VDS approach
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with the Monolith NT.115 (NanoTemper Technologies). Measure-
ments were taken in the absence and in the presence of the natural
feedback inhibitor malate in order to allow or to protect binding of
the C4 selective inhibitor to the allosteric malate inhibitor site.
Binding studies were performed as described in Paulus et al. [19].
Brieﬂy, puriﬁed protein was buffered in KPiN-buffer (50 mM potas-
sium phosphate pH 7.6, 150 mM NaCl, 0.05% (v/v) Tween20) for 2-
(3,4-dihydroxyphenyl)-6,7-dimethylquinoxaline (AG1433) or in
HMGT-buffer (50 mM HEPES/KOH pH 7.6, 10 mM MgCl2, 10% (v/
v) glycerol, 0.05% (v/v) Tween20) for (+)-catechin, ()-epigallocate-
chin gallate and 2-(4-methoxyphenyl)-3-phenyl-quinoxaline. Puri-
ﬁed recombinant C4 PEPC was labeled with NT-547-maleimide or
NT-495-NHS dye (NanoTemper Technologies) according to the
protocol of the manufacturer. Inhibitor compounds identiﬁed in
the VDS approach were dissolved in DMSO or in N,N-Dimethyl-
formamide (DMF) at mM concentrations. For binding studies
compounds were diluted with KPiN-buffer or HMGT-buffer to the
highest concentration applied for the individual compound andFig. 1. Binding position of (+)-catechin and quinoxaline AG 1433 at the allosteric feedb
carboxylase (PEPC). Best predicted binding pose for (+)-catechin (panel a) at the allost
corresponding location of the polyphenol compound at the feedback inhibitor site of non
compound 2-(3,4-dihydroxyphenyl)-6,7-dimethylquinoxaline (AG 1433) at the feedback
in this ﬁgure are in the same relative orientation to allow for easier comparisons of bound
and blue, respectively. Carbon atoms of side chains forming the allosteric feedback in
representation. Numbering is according to PEPC from Flaveria. Carbon atoms for inhib
distinguishable from residues of the malate binding site which are depicted in blue. Resi
and C4 PEPC (glycine) is shown as sphere representation to illustrate that the arginine c
compounds identiﬁed in our screening. The pictures were generated using the programserial diluted in 1:1 steps. The concentration of the solvent was
kept constant in each dilution step. Each dilution step was mixed
with the same volume of the labeled protein. The protein concen-
tration was kept at 0.1 lM for all experiments except for titration
with AG 1433 where a concentration of 0.21 lM was used. The
inhibitor protein mixture was incubated for 30 min at room tem-
perature. Compounds were applied at the following concentrations
(+)-catechin 1–2500 lM, ()-epigallocatechin gallate 0.1–15 lM,
AG 1433 0.005–150 lM and 2-(4-methoxyphenyl)-3-phenyl-quin-
oxaline 0.1–250 lM. All concentrations were measured in tripli-
cate. To demonstrate that the natural inhibitor malate and the
inhibitors identiﬁed in our VDS approach bind at the same site,
the labeled protein was pre-incubated with 200 mM malate for
15 min at room temperature and for AG 1433 at 40 mM malate.
Malate stock solutions were adjusted to pH 7.5 and pH in the bind-
ing assay was controlled to ensure that displacement studies with
malate and controls without malate were measured at the same
pH. The binding constant for catechin, AG 1433 and 2-(4-methoxy-
phenyl)-3-phenyl-quinoxaline were determined from the MSTack inhibitor site of photosynthetic and non-photosynthetic phosphoenolpyruvate
eric feedback inhibitor site of photosynthetic PEPC (C4 PEPC) from F. trinervia and
-photosynthetic PEPC (C3 PEPC) from F. pringlei (panel b). Binding of the quinoxaline
site of C4 PEPC (panel c) and C3 PEPC (panel d) is illustrated below. All of the panels
inhibitors in the two distinct PEPC isoforms. Oxygen and nitrogen are colored in red
hibitor site (malate binding motif) and the docked inhibitors are shown as stick
itors (+)-catechin and AG 1433 are colored in white to make them more easily
due in position 884 of the feedback inhibitor site which differs in C3 PEPC (arginine)
onserved in C3 PEPCs at this position interferes with the binding of the C4 selective
PyMOL (DeLano Scientiﬁc).
Fig. 2. Selective inhibition of C4 PEPC activity by catechins and quinoxalines. Puriﬁed C4 PEPC from F. trinervia and C3 PEPC from F. pringlei were pre-incubated at 25 C for
5 min in the presence of different concentrations of catechins or quinoxaline compounds or in DMSO as a control. PEPC activity was determined by a spectrophotometric-
coupled assay. The plots represent the mean activity relative to the corresponding control plus standard deviation from three experiments. The half maximal inhibitory
concentration (IC50) of the compounds for C4 PEPC (s) and C3 PEPC (d) were obtained from these data by non-linear regression analysis (+)-catechin (a), ()-epigallocatechin
gallate (b), 2-(3,4-dihydroxyphenyl)-6,7-dimethylquinoxaline (AG1433) (c), 2-(4-methoxyphenyl)-3-phenyl-quinoxaline (d).
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ﬂuorescence quench of the NT-495 dye. Dissociation constants
were determined with the GraFit Software (Erithacus Software
Limited, UK). Data from individual experiments were normalized
to the same starting value.
3. Results and discussion
To search for small molecules that selectively bind to the feed-
back inhibitor site of C4 PEPC, we generated a diverse in silico com-
pilation of 12918 small molecules from publicly available libraries
and docked this database of three-dimensional molecules on high
resolution crystal structures of PEPC from F. pringlei (3zgb) and F.
trinervia (3zge) using PyRX 0.8 [20]. From this screening, molecules
showing high binding afﬁnity to the C4 PEPC feedback inhibitor
site, but substantial lower afﬁnity to the C3 PEPC were selected.
To verify selective inhibition of C4 PEPC activity by these com-
pounds puriﬁed PEPC from F. pringlei and F. trinervia was analyzed
by a spectrophotometric-coupled activity assay. In these assays the
concentration of the inhibitors selected from the virtual drug
screening (VDS) was varied to determine the half maximal inhibi-
tory concentration (IC50).
Our computational calculations indicated strong and preferable
interaction of catechins with the C4 PEPC feedback inhibitor
binding site, while binding of this type of polyphenols interferes
with the conserved arginine (aa 884 Flaveria numbering) in the
feedback site of C3 PEPCs (Fig. 1a and b). We tested the effect of
(+)-catechin (predicted binding afﬁnity for C4 PEPC from F. trinervia8.9 kcal mol1) on the activity of C3 and C4 PEPC. Compared to the
natural feedback inhibitor malate showing an IC50 of 2.9 mM for
the C3 PEPC from F. pringlei, but of 8.4 mM for the C4 PEPC from
F. trinervia [18], (+)-catechin was 9-fold more proﬁcient in inhibi-
tion of the non-photosynthetic C3 isoform (IC50 = 307 lM,
Fig. 2a). Inhibition of C4 PEPC is enhanced by a factor of 82
(IC50 = 103 lM, Fig. 2a).
In order to quantify and differentiate the preferred inhibition of
the C4 PEPC by a certain compound we applied the concept of a
selectivity score, which is computed by dividing the IC50 of the
compound for the C3 PEPC by the IC50 obtained with the C4 PEPC.
Thus, a higher selectivity score indicates more potent inhibition
of the C4 isoform. The selectivity score calculated for (+)-catechin
is 3, while the factor obtained for malate is only 0.125 indicating
that the (+)-catechin compound shows a preferential inhibition
of the C4 enzyme in contrast to the natural feedback inhibitor,
which inhibits the C3 isoform more efﬁciently.
Our computations predicted even higher binding afﬁnities of
the C4 enzyme for catechin esters (11 kcal mol1) than for cate-
chins. Additional interactions in the binding site could explain
the superior binding afﬁnity of the catechin esters compared to
the free ﬂavanol compounds. Consequently, we tested the com-
mercially available compound ()-epigallocatechin gallate in our
activity assays. The IC50 for C4 PEPC was lowered by a factor of
7–15 lM reﬂecting the predicted higher binding afﬁnity for the
catechin ester. However, to our surprise the selectivity score
dropped to 2 as the C3 enzyme showed an IC50 of 29 lM for ()-
epigallocatechin gallate (Fig. 2b).
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ing a broad spectrum of biological activities, are the second class
of molecules identiﬁed in our computational calculations that
bind tightly and with high speciﬁcity to the feedback inhibitor
site of C4 PEPC (Fig. 1c and d). The compound 2-(3,4-dihydroxy-
phenyl)-6,7-dimethylquinoxaline (AG1433, predicted binding
afﬁnity for C4 PEPC 9.1 kcal mol1), a potent inhibitor of tyro-
sine kinases [21,22], possessed an IC50 of 39 lM for inhibition
of the F. trinervia PEPC (Fig. 2c) and showed only modest effects
on the activity of the C3 PEPC from F. pringlei. The quinoxaline
derivative 2-(4-methoxyphenyl)-3-phenyl-quinoxaline (predicted
binding afﬁnity for C4 PEPC -9.5 kcal mol1) had a higher IC50
of 65 lM for the inhibition of the F. trinervia C4 PEPC (Fig. 2d).
However, the C3 PEPC from F. pringlei was highly resistant to this
compound and showed no inhibition in the analyzed concentra-
tion range.
Binding of both inhibitor classes, catechins and quinoxalines,
to the feedback inhibitor site in PEPC was veriﬁed by Microscale
Thermophoresis [23,24] showing that the natural feedback inhib-
itor malate can displace the C4 speciﬁc compounds selected from
our computational studies. Dissociation constants of the C4 PEPC
from F. trinervia for (+)-catechin, ()-epigallocatechin gallate
and both quinoxaline derivatives were largely increased in theFig. 3. Interaction of C4 PEPC with catechins and quinoxalines at the allosteric feedback
selected C4 speciﬁc small molecule inhibitors. The PEPC concentration is kept constant at
5 nM. The normalized ﬂuorescence is plotted for analysis of thermophoresis for (+)-catech
of thermophoretic properties observed as a change in ﬂuorescence intensity is stron
epigallocatechin gallate (b) ﬂuorescence quenching was used for binding analysis. The ﬁ
()-epigallocatechin gallate, 2.0 ± 0.7 lM for AG 1433 and 10.2 ± 4.2 lM for 2-(4-meth
inhibitor of C4 PEPC, binding curves for catechins and quinoxaline compounds are shift
lower binding afﬁnity of the small molecule inhibitors is reﬂected by the largely enhance
the binding data in the presence of the natural feedback inhibitor are 276.5 ± 148.2 lM
1433 and 190 ± 10 lM for 2-(4-methoxyphenyl)-3-phenyl-quinoxaline. The error bars rep
measurements.presence of malate (Fig. 3a–d). This conﬁrms our computational
studies predicting that these substances bind to the same site
as the natural feedback inhibitor. The dissociation constant of
AG 1433 (Kd 2 lM) and 2-(4-methoxyphenyl)-3-phenylquinoxa-
line (Kd 10 lM) were shifted about 20-fold in the presence of
malate to 37 lM and 190 lM, respectively. Dissociation constants
of (+)-catechin (Kd 50 lM) and ()-epigallocatechin gallate (Kd
0.6 lM) increased ﬁvefold to 277 lM and 3 lM, respectively,
when the natural inhibitor malate competed for the feedback
binding site.
Our biochemical and biophysical studies conﬁrm that selected
catechins and quinoxaline derivatives are efﬁcient and speciﬁc
inhibitors of the C4 PEPC. The C4 speciﬁc inhibitors were identiﬁed
in our computational analysis with the crystal structures of a clo-
sely related C3 and a C4 PEPC. The fundamental idea of this screen-
ing was to select inhibitors that are structurally unique to target
the feedback inhibitor site in C4 but not in C3 PEPC which differ
in a single amino acid only [18]. To this end, our approach concep-
tually differs from existing virtual screening strategies as it makes
use of two closely related structures – a target and a homologous
non-target negative control – to select for highly selective
inhibitors of the target. Moreover, the molecules identiﬁed in our
study provide a novel molecular mode of action for controllinginhibitor site. Direct interaction study between ﬂuorescently labeled C4 PEPC and
100 nM and the small molecule inhibitors are titrated from about 250 lM to about
in (a), AG 1433 (c) and 2-(4-methoxyphenyl)-3-phenyl-quinoxaline (d). The change
ger in the bound than in the unbound state for all three compounds. For ()-
tted dissociation constants (Kd) are 50.5 ± 8.6 lM for (+)-catechin, 0.6 ± 0.1 lM for
oxyphenyl)-3-phenyl-quinoxaline. In the presence of malate, the natural feedback
ed to lower binding afﬁnities due to binding competition at the allosteric site. The
d Kd values obtained in the presence of malate. Dissociation constants derived from
for (+)-catechin, 3.0 ± 0.9 lM for ()-epigallocatechin gallate, 37.2 ± 11.4 lM for AG
resent the standard deviation of each data point calculated from three independent
2106 J.K. Paulus et al. / FEBS Letters 588 (2014) 2101–2106the catalytic activity of a photosynthetic key enzyme as they
address the allosteric feedback inhibitor site of the target rather
than its catalytic center.
In conclusion, we found two classes of selective inhibitors of the
photosynthetic isoform of PEPC, catechins and quinoxalines. Of
these probes, the quinoxaline derivatives represent the optimal
probes for further development of C4 speciﬁc herbicides as they
show high speciﬁcity for the C4 enzyme, IC50 values in the lower
lM range and no or only modest inhibition of the non-photosyn-
thetic C3 isoform. To our knowledge we report the ﬁrst selective
inhibitors of the photosynthetic isoform of PEPC. These molecules
may foster the development of a unique class of C4 selective
herbicides helping to improve crop yields and to satisfy the
demand of the growing world population for food.4. Competing ﬁnancial interests
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